Your browser doesn't support javascript.
loading
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone.
Kanao, Kent; Takahashi, Takayuki; Umezawa, Yuta; Okabe, Takashi; Kaneko, Go; Shirotake, Suguru; Nishimoto, Koshiro; Oyama, Masafumi.
Afiliación
  • Kanao K; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
  • Takahashi T; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
  • Umezawa Y; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
  • Okabe T; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
  • Kaneko G; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
  • Shirotake S; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
  • Nishimoto K; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
  • Oyama M; Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka-City, Saitama-Pref, Japan.
PLoS One ; 17(10): e0276081, 2022.
Article en En | MEDLINE | ID: mdl-36264927

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Acetato de Abiraterona Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Acetato de Abiraterona Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Japón